Triple negative breast cancer (TNBC), a subset of breast cancer, is defined by the loss of estrogen receptor (ER), progesterone receptor (PgR), human epidermal growth factor receptor type 2 (HER2) expression and the presence of basal-like markers3. Here, ESR1 is linked to breast cancer.